Completed
First-In-Human Clinical Study of the C3 Complement Inhibitor AMY- 101 in Healthy Male Volunteers
NCT03316521
- Conditions
- Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +12 more
- Locations
-
- HighPoint Clinical Trials Center High Point, North Carolina, United States